Depletion of intracellular glutathione increases susceptibility to nitric oxide in mesencephalic dopaminergic neurons

被引:51
作者
Ibi, M
Sawada, H
Kume, T
Katsuki, H
Kaneko, S
Shimohama, S
Akaike, A
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Neuropharmacol, Kyoto 606, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 606, Japan
关键词
glutathione; nitric oxide; glutamate; iron; dopaminergic neuron;
D O I
10.1046/j.1471-4159.1999.731696.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Using primary neuronal cultures, we investigated the effects of GSH depletion on the cytotoxic effects of glutamate and NO in dopaminergic neurons. Intracellular GSH was depleted by 24-h exposure to L-buthionine-[S,R]-sulfoximine (BSO), an irreversible inhibitor of GSH synthase. BSO exposure caused concentration-dependent reduction of the viability of both dopaminergic and nondopaminergic neurons. In contrast, 24-h exposure of cultures to glutamate or NOC18, an NO-releasing agent, significantly reduced the viability of nondopaminergic neurons without affecting that of dopaminergic neurons. Pretreatment with N-acetyl-L-cysteine for 24 h ameliorated the NOC18-induced toxicity in nondopaminergic neurons. In dopaminergic neurons, sublethal concentrations of BSO reduced intracellular GSH content and markedly potentiated glutamate- and NOC18-induced toxicity. These results suggested that glutamate toxicity was enhanced in dopaminergic neurons by suppression of defense mechanisms against NO toxicity under conditions of GSH depletion. Under such conditions, free iron plays an important role because BSO-enhanced NO toxicity was ameliorated by the iron-chelating agent, deferoxamine. These results suggest that GSH plays an important role in the expression of NO-mediated glutamate cytotoxicity in dopaminergic neurons. Free iron may be related to enhanced NO cytotoxicity under GSH depletion.
引用
收藏
页码:1696 / 1703
页数:8
相关论文
共 46 条
[1]
AKAIKE A, 1994, PROG BRAIN RES, V103, P391
[2]
BRAIN PEROXIDASE AND CATALASE IN PARKINSON DISEASE [J].
AMBANI, LM ;
VANWOERT, MH ;
MURPHY, S .
ARCHIVES OF NEUROLOGY, 1975, 32 (02) :114-118
[3]
Bayne K, 1996, Physiologist, V39, P208
[4]
ACONITASE, A 2-FACED PROTEIN - ENZYME AND IRON REGULATORY FACTOR [J].
BEINERT, H ;
KENNEDY, MC .
FASEB JOURNAL, 1993, 7 (15) :1442-1449
[5]
IRON MELANIN INTERACTION AND LIPID-PEROXIDATION - IMPLICATIONS FOR PARKINSONS-DISEASE [J].
BENSHACHAR, D ;
RIEDERER, P ;
YOUDIM, MBH .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (05) :1609-1614
[6]
AGE-RELATED AND PEROXIDATIVE STRESS-RELATED MODIFICATIONS OF THE CEREBRAL ENZYMATIC-ACTIVITIES LINKED TO MITOCHONDRIA AND THE GLUTATHIONE SYSTEM [J].
BENZI, G ;
MORETTI, A .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 19 (01) :77-101
[7]
Glutamate and Parkinson's disease [J].
Blandini, F ;
Porter, RHP ;
Greenamyre, JT .
MOLECULAR NEUROBIOLOGY, 1996, 12 (01) :73-94
[8]
A SYNAPTIC MODEL OF MEMORY - LONG-TERM POTENTIATION IN THE HIPPOCAMPUS [J].
BLISS, TVP ;
COLLINGRIDGE, GL .
NATURE, 1993, 361 (6407) :31-39
[9]
NITRIC-OXIDE MEDIATES GLUTAMATE-LINKED ENHANCEMENT OF CGMP LEVELS IN THE CEREBELLUM [J].
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :9030-9033
[10]
COHEN G, 1990, J NEUR TR S, P229